Bank Mandiri (BMRI IJ) (Buy) - Feb-25: Satisfactory results due to declined provisioning
EWBMRI has released its bank-only Feb-25 results.
-
-
Bank Mandiri (BMRI IJ) (Buy) - Jan-25 Results
EWBMRI started 2025 with satisfactory bank-only Jan-25 results—
-
Bank Mandiri (BMRI IJ) (Buy) - Earnings update, TP adjustment
EWPost FY24 results, we revise our FY25-26F earnings estimates.
-
Bank Mandiri (BMRI IJ) (Buy) - Unexciting (in-line) FY24 results
EWBMRI has released its FY24 results with headline consolidated profit at IDR55.8tn (+1.3% y-y).
-
Bank Mandiri (BMRI IJ) (Buy) - 9M24 – Steady growth
NS EWBMRI released its 9M24 results on 30 October, with the company remaining on a steady growth trajectory.
-
Bank Mandiri (BMRI IJ) (Buy) - Lower risks to growth
NS EWWe took a closer look at BMRI’s provisioning expenses (12MMA CoC) which has stabilised at ~70-80bp in 1H24.
-
Bank Mandiri -BMRI IJ- Buy - Jul-24 results in line with forecast
NS EWBMRI released its bank-only Jul-24 results with monthly earnings
-
Bank Mandiri -BMRI IJ- Buy - Better stability in ROE ROA Re-rating to continue
NS EWThese improvements were largely driven by the bank’s increased